To the Editor,

I have read the article titled "Role of virtual reality in balance training in patients with spinal cord injury: a prospective comparative pre--post study," by Sengupta et al. \[[@b1-asj-2020-0051-r1]\]. The study discusses the use of virtual reality in balance training. However, I would like some of my concerns and queries to be addressed in this issue.

The sample size for this study was calculated based on a pilot study. The effect sizes for pre--post differences in the outcome measures from the Berg Balance Scale (BBS), Functional Reach Score (FRS), and balance section of the Tinetti Performance-Oriented Mobility Assessment (POMA- B) were found to be 0.81, 1.25, and 1.22, respectively. Assuming an acceptable alpha error of 0.5 and aiming for 95% power of the study, the authors found the sample sizes for a two-tailed hypothesis was 22, 11, and 11 for the three outcomes, respectively. However, when the sample sizes for BBS, FRS, and POMA-B were 34, 14, and 16, respectively, when calculated using the G\*Power software (Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany; <http://www.gpower.hhu.de/>) based on the above criteria \[[@b2-asj-2020-0051-r1]\].

In addition, on page 54, Fig. 1 of Sengupta et al. \[[@b1-asj-2020-0051-r1]\], the authors mentioned follow-up in all areas of allocation, follow-up, and analysis, which are not appropriate \[[@b3-asj-2020-0051-r1]\].

The authors did not test for normality because of small sample size. According to central limit theorem, violation of normality is not a major issue with sample size ≥100, but to draw meaningful conclusions, assumption of normality should be followed regardless of the sample size. Continuous data with a normal distribution should be presented as mean values, and significance levels (*p*-values) between and among the groups should be calculated using the mean value. However, for data with non-normal distribution, the resultant mean is not a representative of the data. Selecting the wrong representative data and calculating the significance level using this value might lead to a wrong interpretation. Therefore, testing for normality of data is important. The decision can be taken as to whether the mean is applicable as a representative value of the data. If applicable, a parametric test is used to compare means, otherwise medians are used to compare the groups using nonparametric methods \[[@b4-asj-2020-0051-r1]\].
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